Cloned cDNA sequence for the human mesothelial protein 'mesosecrin' discloses its identity as a plasminogen activator inhibitor (PAI-1) and a recent evolutionary change in transcript processing - PubMed (original) (raw)
. 1989 Sep:94 ( Pt 1):1-10.
doi: 10.1242/jcs.94.1.1.
Affiliations
- PMID: 2613765
- DOI: 10.1242/jcs.94.1.1
Cloned cDNA sequence for the human mesothelial protein 'mesosecrin' discloses its identity as a plasminogen activator inhibitor (PAI-1) and a recent evolutionary change in transcript processing
G T Cicila et al. J Cell Sci. 1989 Sep.
Abstract
Mesosecrin, a Mr approximately 46 x 10(3) glycoprotein secreted in abundance by human mesothelial cells in culture, was recently described by this laboratory. We isolated partial cDNA clones for mesosecrin from a human mesothelial cell cDNA library in lambda gt11 using a specific antiserum. Comparison of mesosecrin cDNA sequences with the recently published sequence for plasminogen activator inhibitor-1 (PAI-1) cloned from cDNA libraries of endothelial and other cell types revealed that mesosecrin and PAI-1 are the same protein. Reverse fibrin autography of electrophoretically fractionated medium from mesothelial cell cultures confirmed that mesosecrin is functional as a plasminogen activator inhibitor. The mesosecrin/PAI-1 cDNA clones hybridized to abundant 3.6 and 2.6 kb (kb = 10(3) bases) mRNAs on Northern blots of cultured human mesothelial cell and endothelial cell RNA. These mRNA sizes correspond to those recently published for human endothelial and fibrosarcoma PAI-1 mRNA, which most likely result from alternate polyadenylation sites. Messages 3.6 and 2.6 kb long were also detected in cells cultured from orangutans and African green monkeys, but only an approximately 3.6 kb mRNA was detected in cells of lower primates and several other mammalian species. Thus the extra polyadenylation site in the PAI-1 gene, responsible for the shorter form of the RNA, apparently has been acquired recently during primate evolution. Because they are more easily propagated in culture than endothelial cells, human mesothelial cells offer a new and advantageous system for PAI-1 production and study of its regulation and function.
Similar articles
- Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA.
Fattal PG, Billadello JJ. Fattal PG, et al. Nucleic Acids Res. 1993 Mar 25;21(6):1463-6. doi: 10.1093/nar/21.6.1463. Nucleic Acids Res. 1993. PMID: 8464738 Free PMC article. - Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.
Ny T, Sawdey M, Lawrence D, Millan JL, Loskutoff DJ. Ny T, et al. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6776-80. doi: 10.1073/pnas.83.18.6776. Proc Natl Acad Sci U S A. 1986. PMID: 3092219 Free PMC article. - cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.
Ginsburg D, Zeheb R, Yang AY, Rafferty UM, Andreasen PA, Nielsen L, Dano K, Lebo RV, Gelehrter TD. Ginsburg D, et al. J Clin Invest. 1986 Dec;78(6):1673-80. doi: 10.1172/JCI112761. J Clin Invest. 1986. PMID: 3097076 Free PMC article. - cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.
Ye RD, Wun TC, Sadler JE. Ye RD, et al. J Biol Chem. 1987 Mar 15;262(8):3718-25. J Biol Chem. 1987. PMID: 3029122 - Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.
Pannekoek H, Veerman H, Lambers H, Diergaarde P, Verweij CL, van Zonneveld AJ, van Mourik JA. Pannekoek H, et al. EMBO J. 1986 Oct;5(10):2539-44. doi: 10.1002/j.1460-2075.1986.tb04532.x. EMBO J. 1986. PMID: 2430793 Free PMC article.
Cited by
- Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA.
Fattal PG, Billadello JJ. Fattal PG, et al. Nucleic Acids Res. 1993 Mar 25;21(6):1463-6. doi: 10.1093/nar/21.6.1463. Nucleic Acids Res. 1993. PMID: 8464738 Free PMC article. - The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1.
Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G. Serini G, et al. J Cell Biol. 1998 Aug 10;142(3):873-81. doi: 10.1083/jcb.142.3.873. J Cell Biol. 1998. PMID: 9700173 Free PMC article. - Tumour necrosis factor-mediated release of plasminogen activator inhibitor 1 by human peritoneal mesothelial cells.
Whawell SA, Scott-Coombes DM, Vipond MN, Tebbutt SJ, Thompson JN. Whawell SA, et al. Br J Surg. 1994 Feb;81(2):214-6. doi: 10.1002/bjs.1800810218. Br J Surg. 1994. PMID: 8156339 Free PMC article. - Close similarity between cultured human omental mesothelial cells and endothelial cells in cytochemical markers and plasminogen activator production.
Takahashi K, Hata J, Mukai K, Sawasaki Y. Takahashi K, et al. In Vitro Cell Dev Biol. 1991 Jul;27A(7):542-8. doi: 10.1007/BF02631284. In Vitro Cell Dev Biol. 1991. PMID: 1716252
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous